Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages
about
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant PathogensMixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulationInfluence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent.Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophilaDifferential immune responses to Segniliparus rotundus and Segniliparus rugosus infection and analysis of their comparative virulence profiles.Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria.Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.Moxifloxacin in the treatment of skin and skin structure infections.Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosisCellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenoActivities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureusPharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: In vitro and clinical release studies.Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity.Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin.Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells.Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.Measurement of Salmonella enterica Internalization and Vacuole Lysis in Epithelial Cells.Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages.Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides.Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo.Antibiotic resistance: a rundown of a global crisis
P2860
Q28546863-B6CC2B1B-B9B5-46A6-9687-F32D0B5882DFQ33770082-9E78AB0A-22AD-4EE2-B377-CD46A254B6BDQ33836590-A698157B-EFA6-4B62-B550-EC982085B85AQ33876454-6D3C25CF-F546-4141-B2D4-CF17DF8DE51BQ34308628-BC4BA4A1-141B-47BD-8E90-A6A156990D3CQ34440983-7882473C-8F0E-4F2A-99CE-E4609C0D1643Q34509728-FF527198-4FB0-4902-BEE7-4C0DD440E074Q34528916-E1D438AC-5C55-4C4A-9309-1D832579681FQ34618656-80396A5B-8148-4BCA-9874-63EFE484C0E5Q34651775-BF7DDB98-D044-4319-B1E7-570971D14E1AQ34737534-82350CB0-0D51-40E7-B544-BD57A4774926Q35636012-B35272A5-B761-4956-9855-9C4FEDCF552BQ35637071-7977E3A3-33A3-421E-8CA8-85796C82E82AQ35912731-4951E493-BE8A-4D1F-8F77-8FC59955740DQ35919259-C7B4832F-511B-4A03-A3DB-0C19A95C7A4EQ35943844-BFC9264B-21E8-4387-8602-27321B6A8D6BQ36660619-9B45FE5B-4C29-402D-AEDC-F6C129065961Q36669451-31C2D7D3-DE80-40DE-BC9B-B72FAEE2D9C8Q36670964-FA34D43A-D3AC-4D0C-BDD9-E8637D3ED136Q36757725-A6F4CD7D-D0CB-427A-9A99-C94A8B08F8D8Q36804044-11C593C1-917E-4AC2-A3D5-2B6F238C18CAQ37144809-8BD73F6A-D47C-4A8D-9BE3-CDEE42AD8CD4Q37204106-6C6C426A-C2CD-4750-8811-C8DBD10B8993Q37304630-0B1AF4D5-C974-4738-8F96-59E75D7BAB3AQ37409954-BB6A8009-01C4-442B-BE18-B6FC71D86F0DQ38646905-D54611FF-7B76-4DC3-A932-EC15D5D771BEQ39048725-43D241A7-C450-47BD-BA15-A6E539D41C22Q39352419-5FB84DB4-7F50-4941-8B03-518D0751B6ECQ39373932-7DA94FAD-4ACB-4DEF-88FE-6BEC6267CC3DQ39789428-1714C121-2D02-4C3C-9209-56BECAA5A897Q39831380-0C12452A-FB72-454D-B4DA-282D4D354F23Q40028791-652124FD-57C5-4B96-80CF-805AFEAB9F3DQ41476422-437C4C4D-4013-404D-AA04-ECF073748426Q41913957-415D08B2-45C0-4EFE-85AE-7894B402922FQ42932532-20BF206A-20CE-4CF6-B9B8-17B92D8AFDD2Q47784438-9A07F7C8-3900-484E-8AC0-BC2772796ABEQ50053159-E85C0173-44C4-4E8E-A8F0-8C7B55085922Q51742014-B87B1537-0D06-4AEB-BBE1-C1AE13657C89Q57816209-B62952BD-69D5-4DF4-B11C-4911AC6FE743
P2860
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@ast
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@en
type
label
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@ast
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@en
prefLabel
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@ast
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@en
P2860
P1476
Quantitative analysis of genta ...... reus in mouse J774 macrophages
@en
P2093
Cristina Seral
P2860
P304
P356
10.1128/AAC.47.7.2283-2292.2003
P407
P577
2003-07-01T00:00:00Z